» Articles » PMID: 30239993

CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Citing Articles

Ten-year experience with pharmacogenetic testing for in a national cancer center in Italy: Lessons learned on the path to implementation.

Bignucolo A, De Mattia E, Roncato R, Peruzzi E, Scarabel L, DAndrea M Front Pharmacol. 2023; 14:1199462.

PMID: 37256229 PMC: 10225682. DOI: 10.3389/fphar.2023.1199462.


From pharmacogenetics to pharmaco-omics: Milestones and future directions.

Auwerx C, Sadler M, Reymond A, Kutalik Z HGG Adv. 2022; 3(2):100100.

PMID: 35373152 PMC: 8971318. DOI: 10.1016/j.xhgg.2022.100100.


Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.

Koromina M, Koutsilieri S, Patrinos G Hum Genomics. 2020; 14(1):4.

PMID: 31941550 PMC: 6964087. DOI: 10.1186/s40246-019-0254-y.


Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.

Davila-Fajardo C, Diaz-Villamarin X, Antunez-Rodriguez A, Fernandez-Gomez A, Garcia-Navas P, Martinez-Gonzalez L Genes (Basel). 2019; 10(4).

PMID: 30939847 PMC: 6523655. DOI: 10.3390/genes10040261.